OverviewChartNewsTraderScreen

LBBW Aktienanleihe SNW 28.02.2025/  DE000LB40KW9  /

Frankfurt Zert./LBB
2025-01-03  5:15:13 PM Chg.-0.010 Bid2025-01-03 Ask2025-01-03 Underlying Strike price Expiration date Option type
99.880EUR -0.01% -
Bid Size: -		 -
Ask Size: -		 SANOFI SA INHABER ... 72.00 EUR 2025-02-28 Call
TeleTrader 2024-12-31 Europe opens year-end session with losses
TeleTrader 2024-11-22 Europe closes higher, FTSE up over 1%
TeleTrader 2024-10-25 Europe closes mixed amid earnings, data
TeleTrader 2024-10-25 Europe lower in premarket as financial results pour in
TeleTrader 2024-10-25 Sanofi's Q3 net sales up by 15.7% to €13.44 billion
TeleTrader 2024-10-21 Sanofi in talks with CD&R for 50% stake in Opella
GlobeNewswire 2024-09-02 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 2024-08-26 Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire 2024-08-14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 2024-08-13 Vigil Neuroscience Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 2024-08-12 MeiraGTx Announces $50 Million Offering of Ordinary Shares led by Sanofi and Reports Second Quarter ...
GlobeNewswire 2024-08-12 MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi
GlobeNewswire 2024-08-08 Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free sur...
GlobeNewswire 2024-08-07 Kymera Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire 2024-08-06 Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D ...
GlobeNewswire 2024-08-05 Fierce Biotech Names Recludix Pharma a “Fierce 15” Biotech Company of 2024
GlobeNewswire 2024-08-02 Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
GlobeNewswire 2024-08-01 Denali Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 2024-08-01 Regeneron Reports Second Quarter 2024 Financial and Operating Results
GlobeNewswire 2024-07-31 Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2...
GlobeNewswire 2024-07-25 Press Release: Online availability of Sanofi’s half-year financial report for 2024
TeleTrader 2024-07-25 Europe lower premarket as earnings pour in
TeleTrader 2024-07-25 Sanofi net sales up 7.8% to €10.7B in Q2
GlobeNewswire 2024-07-25 Press Release: Sanofi Q2 - strong performance with 10% sales growth; 2024 guidance upgraded
GlobeNewswire 2024-07-24 US Hematologists Express High Unmet Need in Treatments for Warm Autoimmune Hemolytic Anemia and Cold...